Efficacy of pneumococcal vaccination in adults: a meta-analysis. - sprookjes - yvandenbroek - TriplyDB

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

http://www.wikidata.org/entity/Q34657877

about

Vaccines for preventing pneumococcal infection in adults Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-Analysis Adult vaccination Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines Cardiotoxicity during invasive pneumococcal disease Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study [Vaccination against pneumococci and influenza. How good is the evidence?].Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke.Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older Persistence and complex evolution of fluoroquinolone-resistant Streptococcus pneumoniae clone.Polysaccharide-specific B cell responses to vaccination in humans Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation.Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.Management of community-acquired pneumonia in older adults.Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis.Prediction of pneumonia hospitalization in adults using health checkup data Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage.Vaccine herd effect.Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up Development of Streptococcus pneumoniae Vaccines Using Live Vectors Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306.Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe.Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization.Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey.Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study.Recurrent severe invasive pneumococcal disease in an adult with previously unknown hyposplenia.Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil.

P2860

Q24201474-11C079EB-572B-4A59-9836-8432899F21D1 Q26770693-82957730-8E20-4157-B439-336A04B2CE36 Q26772119-C432813E-C513-4F64-8C55-396F64E365F7 Q26824961-6F1C3B9F-7B9E-4A38-AC1D-F851F489BCB4 Q28070059-BBA88A3C-9192-4336-B14B-6D1F30E3F6A3 Q28077703-284864E3-AF83-45FD-A1C5-A8A3A3742A91 Q28081769-BE11D525-4B7E-41DF-B485-075E8C3DF2E1 Q28604186-AE556172-D297-4189-AE74-52B39237438E Q30395309-8840C10A-393B-44C4-A321-B718F4EE1FB7 Q33525198-9FC5E680-8F54-4A2E-BA7F-C2089A22189B Q33542866-1B7377E5-9238-409B-87CC-81F85C80B597 Q33577091-03724C92-8C9C-49DA-A3E9-472A1778B642 Q33577958-E012F495-0B56-450A-A772-E184935F2A19 Q33601853-980FD776-BD1E-4901-964E-ED4F625105D0 Q33614101-266C3F4F-45F8-4F8C-BCE6-7C2894380C08 Q33622001-97984E49-178A-4261-9EF4-FF2D95F1EA14 Q33675229-9428A034-F93A-4408-BB16-2C9A51419AC4 Q33713522-56C7D2F8-2990-4783-8CFF-910B39115D8B Q33719116-E0713711-D530-4E95-B4FD-E2F117B3C95A Q33810591-DBF3BBD8-3FC8-43F4-A5C1-A888E3848FFD Q33831860-52471920-B555-4819-A1DD-E772F7A8C516 Q33853406-F9D9DD74-6D16-40EB-8D3D-9FCC30BADCE3 Q33947633-BBF93763-0B05-4FC8-892A-723877DCDB21 Q33963100-371184E5-1A5F-414A-805B-764E8BCE834E Q34092339-764FDC62-4208-445F-824B-DDB336EC3CA5 Q34186752-DDE98786-9734-4CED-9558-216FB8BBFF05 Q34204883-BAE7D154-8CF8-4641-A0FD-342B37529B99 Q34316015-6365AD70-94DF-46B7-92B1-00FEEAC588B4 Q34388781-972D29B5-2DF5-4128-87C4-EE0706E8C0C1 Q34402444-DC259362-B8F8-42BC-A48C-D9873D5CA9A4 Q35021112-289E548F-C422-4FFB-AD60-C7E78C779997 Q35021125-EDA331BD-D514-40C2-AADB-2C2201B98A6F Q35154329-BCA5A84F-AB96-4EDD-8CE3-274CDEE79D93 Q35156164-AAB84D60-D037-4832-97EC-B66BA248103E Q35194846-D7D38FF7-1384-4AAB-A8ED-5E9C3198CCE3 Q35199208-B2B63BF7-1FBE-4DCD-9F39-D5536E7A9186 Q35319990-90ADA01A-CFB0-4283-A050-9A582FBCA812 Q35532366-FB8572FC-7373-4BE9-B36E-6B6AA549852E Q35598060-030AD0BD-5320-4DFA-8A59-53AE4CEEBCD4 Q35667357-FE05310F-06BB-4E3E-B28B-492B8AD741C2

P2860

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

http://www.wikidata.org/entity/Q34657877

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@ast

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@en

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@nl

type

label

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@ast

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@en

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@nl

prefLabel

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@ast

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@en

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@nl

P1433

Q34657877-487EF815-16A5-4FB6-B07E-B469F2B50656

P1476

Q34657877-61D2888D-659A-4EEE-AAA3-69FA157CB609

P2093

Q34657877-5FE9AD25-82DA-4B1B-BCDC-796C8AE5A86C

Q34657877-FDFC0D3D-8271-4D21-9FBD-FB7159130578

P2860

Q34657877-0513E274-0A9B-425F-9EFB-41BBECA9A6A3

Q34657877-0A62853F-71EF-4327-852C-C078A089B33E

Q34657877-0B5300AE-8D79-4D57-BC59-FBF75B7D6A38

Q34657877-0B6252E0-8949-454F-9CA0-61CE7BA522F7

Q34657877-160F4527-205B-4D6D-BDE0-8ECEA59B57F1

Q34657877-1A607AFF-F9E4-481B-A5B3-1993FBCC4440

Q34657877-203B781A-9F07-4EB2-93D0-51EF12769B0A

Q34657877-26A909F8-DFB9-4BD1-B82D-55003798709C

Q34657877-2A204E2D-E04D-4CC7-863F-17C13E596642

Q34657877-2F05BA2B-F328-4EBB-9226-6E17E7CCFC0E

P304

Q34657877-C03695AA-E10D-481E-A9A5-CC9651385F3A

P31

Q34657877-04d4652c-a8e9-4670-a28d-580beec3c822

Q34657877-119C04C6-9590-488C-9C7A-93004D878DC5

P356

Q34657877-6C1E4AE0-1643-4578-B9DC-C7F4003B5ADB

P407

Q34657877-17E46203-95F4-424A-959D-87BCE80616F2

P433

Q34657877-BCB3D455-3A04-4637-8A64-97C80DB6E310

P478

Q34657877-C652DD3E-6BC2-483E-BC42-BCD4127E9F5D

P50

Q34657877-54E75D57-31EC-48C0-8318-63E26C618FA4

Q34657877-A24D5C7F-09B6-4C8F-9AB5-8116D04AE9C7

Q34657877-E6397D7F-A7A2-4BAD-A09E-8EB1D63166DF

P577

Q34657877-A04ED475-2BDF-4E69-9816-812F6F6C40D4

P5875

Q34657877-AD24FD33-FB65-4154-AE48-D52526FF99EC

P698

Q34657877-18D26178-8CA2-461E-B35F-91F14F92A5C1

P921

Q34657877-67FB5766-06EF-4788-B4D7-AA6B92E35A76

P932

Q34657877-738078A2-9664-415F-B528-19FB798158F9

P356

P1433

Canadian Medical Association Journal

P1476

Efficacy of pneumococcal vaccination in adults: a meta-analysis.

@en

P2093

Andreas E Stuck

http://www.w3.org/2001/XMLSchema#string

Anke Huss

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccines for preventing pneumococcal infection in adults

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

Pneumococcal vaccination during pregnancy for preventing infant infection

Pneumococcal vaccines for children and adults with bronchiectasis

Pneumococcal vaccines for sickle cell disease

Pneumococcal vaccines for preventing otitis media

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

Bias in meta-analysis detected by a simple, graphical test

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

P304

48-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.080734

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Trotter

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23759832

http://www.w3.org/2001/XMLSchema#string

P698

19124790

http://www.w3.org/2001/XMLSchema#string

P921

P932

2612051

http://www.w3.org/2001/XMLSchema#string